Page last updated: 2024-10-20

urea and Mucopolysaccharidosis I

urea has been researched along with Mucopolysaccharidosis I in 1 studies

pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.

Mucopolysaccharidosis I: Systemic lysosomal storage disease caused by a deficiency of alpha-L-iduronidase (IDURONIDASE) and characterized by progressive physical deterioration with urinary excretion of DERMATAN SULFATE and HEPARAN SULFATE. There are three recognized phenotypes representing a spectrum of clinical severity from severe to mild: Hurler syndrome, Hurler-Scheie syndrome and Scheie syndrome (formerly mucopolysaccharidosis V). Symptoms may include DWARFISM; hepatosplenomegaly; thick, coarse facial features with low nasal bridge; corneal clouding; cardiac complications; and noisy breathing.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
CHRISTIAENS, L1
WALBAUM, R1
FARRIAUX, JP1
CUVELIER, R1

Other Studies

1 other study available for urea and Mucopolysaccharidosis I

ArticleYear
[HURLER'S DISEASE IN AN INFANT: CYTOLOGICAL AND BIOCHEMICAL STUDY].
    Pediatrie, 1964, Volume: 19

    Topics: Aspartate Aminotransferases; Blood Cell Count; Blood Protein Disorders; Bone Marrow Examination; Cli

1964